Cargando…
Glycaemic Effects of Non-statin Lipid-Lowering Therapies
Since the publication of the JUPITER trial, attention has been focused on the adverse glycemic effects of statin therapy. Although the modest increase in the risk of new diabetes mellitus is outweighed by the reduction in cardiovascular events for statins, emerging biochemical and genetic links betw...
Autores principales: | Collins, Patrick D., Sattar, Naveed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116040/ https://www.ncbi.nlm.nih.gov/pubmed/27864787 http://dx.doi.org/10.1007/s11886-016-0795-9 |
Ejemplares similares
-
Next Generation of Weight Management Medications: Implications for Diabetes and CVD Risk
por: Wharton, S., et al.
Publicado: (2015) -
Current Considerations in Emergency Airway Management
por: Pirotte, Andrew, et al.
Publicado: (2022) -
Patterns of weight change after the diagnosis of type 2 diabetes in Scotland and their relationship with glycaemic control, mortality and cardiovascular outcomes: a retrospective cohort study
por: Aucott, Lorna S, et al.
Publicado: (2016) -
Antiplatelet Therapy for Every Diabetic Person?
por: Nicolucci, Antonio, et al.
Publicado: (2011) -
Should C-Reactive Protein Be a Target of Therapy?
por: Oh, Jisun, et al.
Publicado: (2011)